Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Proliferative Retinopathies (AMD and PDR)
NCT00776763Phase 2Completed
- Sponsor
- Ophthalmological Association Edelweiss
- Start
- Oct 2008
- Primary completion
- Oct 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in proliferative diabetic retinopathy (PDR), age-related macular degeneration (AMD), sponsored by Ophthalmological Association Edelweiss. Started Oct 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00776763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00776763.